Genetics

Genome-editing tool could increase cancer risk

Therapeutic use of gene editing with the CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published ...

Diseases, Conditions, Syndromes

Mapping the global burden of sickle cell anaemia

The first rigorous study to assess the global burden of sickle cell anaemia in recent times is reported today in the Lancet, giving an up-to-date view of the distribution of the disease. Accurate estimates of the numbers ...

Genetics

Genome editing at the crossroads of scandal and cure

Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics. Jacob Corn explains the difference.

Diseases, Conditions, Syndromes

One day, science may cure sickle cell anaemia

Genetic mutations that affect our blood cells' haemoglobin are the most common of all mutations. It has been estimated that around 5% of the world's population carry a defective globin gene.

page 1 from 2